๐ฐ Murray Kessler News
Page 2 - Murray Kessler News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Murray Kessler. Real-time updates on events, politics, business and more.
May 11, 2023
The U.S. Food and Drug Administration unanimously voted Wednesday in favor of recommending the first-ever over-the-counter birth control pill, saying benefits outweigh risks. The vote is a major step in a long push to make oral contraception obtainable over the counter in the United States.
May 11, 2023
If approved, Opill will become theย first birth control pill available in the US without a prescription, giving women control of their bodies again.
May 10, 2023
WEDNESDAY, May 10, 2023 (HealthDay News) -- In a unanimous vote, a panel of expert advisors to the U.S. Food and Drug Administration on Wednesday endorsed the over-the-counter sale of
May 10, 2023
Prices in the category rose by 4.3% in April from the prior month, said the Bureau of Labor Statistics. From a year ago, prices are up 8.8%.
May 10, 2023
WEDNESDAY, May 10, 2023 (HealthDay News) -- In a unanimous vote, a panel of expert advisers to the U.S. Food and Drug Administration on Wednesday endorsed the over-the-counter (OTC) sale
May 10, 2023
Two FDA advisory panels agreed that people would use Opill safely and effectively.
May 10, 2023
Advisers for the US Food and Drug Administration voted unanimously on Wednesday in support of making the birth-control pill Opill available over-the-counter, saying the benefits outweigh the risks.
May 10, 2023
Prices of baby food and formula hit an all-time high last month as suppliers rushed to adjust to new government guidance to avoid another shortage.
May 9, 2023
Perrigo Company plc (PRGO) announced that Murray Kessler has notified the company of his intent to retire as President and Chief Executive Officer, with a target effective date of July 31, 2023.
March 29, 2023
GRAND RAPIDS — Perrigo Co. plc is now scheduled to make a pitch in May to federal regulators who will decide whether to approve an over-the-counter daily birth control pill for the U.S. market. The company said Tuesday that the U.S. Food and Drug Administration rescheduled a joint meeting ofโฆ